Search - tctmd.com

Displaying 21 - 40 of 296

Sort: Relevancy | Date

News Daily News

High-Sensitivity Troponin Tests Might Aid in Primary Prevention

Yael L. Maxwell

April 16, 2025

News Opinion CV Team Dispatch

March 2025 Dispatch for the CV Team

L.A. McKeown

March 21, 2025

News Daily News

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Michael O'Riordan

March 06, 2025

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

L.A. McKeown

March 06, 2025

News Daily News

Danish Analysis Updates Stroke and MI Risks of Contemporary Contraceptives

L.A. McKeown

March 03, 2025

News Daily News

Finerenone Cuts Intensification of Oral Diuretics in Outpatient Setting: FINEARTS-HF

Michael O'Riordan

March 03, 2025

Genetic Risk Score for Endothelial Cell Dysfunction Identifies Patients at Risk

News Daily News

Genetic Risk Score for Endothelial Cell Dysfunction May Help Hone ASCVD Care

Michael O'Riordan

February 27, 2025

News Daily News

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

Michael O'Riordan

February 24, 2025

News Opinion CV Team Dispatch

February 2025 Dispatch for the CV Team

L.A. McKeown

February 01, 2025

News Opinion CV Team Dispatch

January 2025 Dispatch for the CV Team

L.A. McKeown

January 24, 2025

News Daily News

CVD Risks Vary by Type of Menopausal Hormone Replacement Therapy

Todd Neale

December 04, 2024

News Opinion CV Team Dispatch

November 2024 Dispatch for the CV Team

L.A. McKeown

November 26, 2024

News Features

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

Todd Neale

November 13, 2024

News Opinion CV Team Dispatch

October 2024 Dispatch for the CV Team

L.A. McKeown

October 25, 2024

News Conference News HFSA 2024

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

Michael O'Riordan

October 02, 2024

News Conference News ESC 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Michael O'Riordan

September 01, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Conference News ESC 2024

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

Caitlin E. Cox

August 31, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

Yael L. Maxwell

August 19, 2024

Advertisement

High-Sensitivity Troponin Tests Might Aid in Primary Prevention

March 2025 Dispatch for the CV Team

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

Danish Analysis Updates Stroke and MI Risks of Contemporary Contraceptives

Finerenone Cuts Intensification of Oral Diuretics in Outpatient Setting: FINEARTS-HF

Genetic Risk Score for Endothelial Cell Dysfunction May Help Hone ASCVD Care

Invasive Testing Safely Diagnoses Microvascular Dysfunction in ANOCA

February 2025 Dispatch for the CV Team

January 2025 Dispatch for the CV Team

CVD Risks Vary by Type of Menopausal Hormone Replacement Therapy

November 2024 Dispatch for the CV Team

GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix?

October 2024 Dispatch for the CV Team

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

September 2024 Dispatch for the CV Team

Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content